GSK

News

Walmsley to leave GSK in surprise exit

This week has kicked off with the news that Emma Walmsley is standing down as chief executive of GSK after eight years, to be replaced by Luke Miels.

News

As Trump visits UK, GSK pledges $30bn in US investment

GSK's investment drive includes a new facility in Pennsylvania, and follows some high-profile abandoned projects by drugmakers in the UK.

Digital

The AI drug discovery race: Who’s leading the charge?

News

UK adds chickenpox to childhood vaccination schedule

The UK will offer free vaccination against chickenpox to young children from the start of 2026, in the hope of eliminating cases in a couple of years.

News

Dynavax has GSK's shingles vaccine in its sights

Big pharma group GSK has been ruling the market for shingles vaccines for many years, but little Dynavax wants to knock off its crown.

News

Iterum brings first oral penem antibiotic to US market

Iterum has launched Orlynvah as a treatment for uncomplicated urinary tract infections (uUTIs), the first oral option in the go-to penem class.

Walmsley to leave GSK in surprise exit

As Trump visits UK, GSK pledges $30bn in US investment

The AI drug discovery race: Who’s leading the charge?

UK adds chickenpox to childhood vaccination schedule

Dynavax has GSK's shingles vaccine in its sights

Iterum brings first oral penem antibiotic to US market

Remepy's hybrid Parkinson's therapy poised for phase 3

Discover a new era of healthcare panel engagement: Grounded ...

GSK

Editor's Picks